Inside the FDA's Case Against Kabana Skin Care: How a 'Clean' Sunscreen Brand Failed the Basics

February 19, 2025. Two FDA drug inspectors walked into Kabana Skin Care's New Mexico manufacturing site for a routine audit. They left with enough evidence to shut the drug side of the business down.

Kabana was small. A Colorado family shop that pressed zinc oxide sticks and tinted mineral SPFs and sold them at yoga studios, natural grocers, and one small section of Whole Foods. Their pitch was the pitch you see on a thousand other tubes now: no fragrance, no petrochemicals, plant based ingredients, third generation family owners.

By March 12, 2025, the FDA had documented enough violations that Kabana voluntarily recalled 100% of its over the counter drug lineup, roughly 508 total tubes and bottles across three states, per Newsweek's July 11, 2025 report on the enforcement filing. Then, in a formal July 18, 2025 warning letter, the agency wrote that Kabana did not perform chemical or microbiological tests on your finished drug products prior to release into the market. Every mineral SPF the company shipped went out without a lab confirming the zinc actually dispersed, that the batch was free of bacteria, or that the SPF number on the front of the tube matched what was inside.

The pattern isn't rare. The FDA's own 2020 review of methanol contaminated hand sanitizers pulled more than 200 brands from US shelves for a nearly identical class of failure, and the agency's public warning letter database shows small over the counter drug makers cited for cGMP violations year after year, most of them for skipping the same finished product test Kabana skipped.

What is Kabana Skin Care, and what did it make?

Kabana Skin Care LLC operated from Louisville, Colorado, with drug manufacturing in New Mexico. Its four flagship over the counter drug products, all mineral zinc oxide sunscreens, were:

• Green Screen SPF 32 (Kabana's own brand)
• B Natural Organics Organic Sunscreen SPF 30 (a contract job)
• Erin's Faces Mineral SPF 32 (another contract job)
• In Your Face Mineral Tint SPF 31 (Kabana's own tint)

The affected lots totalled 204 tubes of B Natural Organics SPF 30, 174 tubes of Green Screen SPF 32, 76 bottles of the In Your Face tint, and 54 tubes of Erin's Faces SPF 32. Small numbers. The FDA still classified the recall as Class II, meaning a reasonable probability that use could cause temporary or medically reversible harm.

What the FDA warning letter actually says

The letter is unusually blunt. FDA inspectors visited Kabana's manufacturing site on February 19 and 20, 2025. They wrote up three failures. First, Kabana didn't test incoming raw materials, in particular the ethanol and glycerin used as solvents and bases, for hazardous contaminants like methanol, diethylene glycol, and ethylene glycol. Second, Kabana skipped the lab step that confirms a finished tube actually contains what its label says it does. No potency assay, no microbial count, no stability panel. Third, the quality unit that was supposed to catch these gaps didn't have written procedures for raw material review, batch records, equipment maintenance, or process controls. Every safeguard the cGMP rules require was missing, not just weakened. That's why the FDA acted so quickly and why Kabana stopped shipping the same day it recalled.

Why methanol screening is the test people keep skipping

The methanol point sounds boring on paper. It isn't. Glycerin and ethanol are commodity ingredients, cheap, made at industrial scale, and often traded through brokers who blend batches from many refiners. When a broker's supply is contaminated, every downstream product inherits the problem.

People die when this test gets skipped.

A 2023 WHO analysis linked contaminated glycerin to over 300 pediatric deaths across Gambia, Indonesia, and Uzbekistan, all from cough syrups made with the same class of solvent Kabana never tested. Testing glycerin for methanol takes a lab about ten minutes and costs a few dollars per drum. It's the single cheapest safety check in the entire drug supply chain.

Are Kabana's mineral SPFs actually dangerous to use?

Probably not dangerous the way a contaminated cough syrup is dangerous. Nobody's been hospitalized from a Kabana tube, and no batch has publicly tested positive for methanol or bacteria. The recall is a probability call, not a confirmed harm call. Two failure modes are still plausible.

The first is microbial contamination. A sunscreen sits on a hot bathroom counter for months, and a batch that was never checked for bacterial load could support growth, which is exactly why the finished product microbial count is a cGMP requirement and not a nice to have.

The second is SPF drift. When a mineral formula isn't tested for zinc dispersion, the actual UV protection can trail the label by a wide margin, and independent SPF retesting programs have historically found label vs measured gaps of more than 30% in a meaningful share of tested products. If you own a tube from a recalled Kabana lot, the reasonable move is to throw it out and pick another mineral SPF this weekend.

How a 'clean' brand slipped past its own quality control

This is the part I've been thinking about most. Kabana wasn't a shell company. Its founder is a chemist. The website talks openly about small batch production and lists actual INCI names, which is more than most brands do.

Values are not a lab test.

When you read the warning letter alongside the marketing copy, you get a portrait of a company that thought values were enough. Plant based, family owned, third generation, no fragrance. All true. None of it is a chemical assay.

The gap FDA exposed is a gap the whole clean beauty aisle has. As we've argued before, most of the claims on the front of a bottle are unregulated. "Clean" has no legal definition. "Natural" has no legal definition. "Dermatologist tested" can mean one derm looked at it. The one label that is regulated is the SPF number, and it requires running the drug side of the business with drug grade discipline. The plant based pitch does not exempt anyone from that.

The economics make the gap almost inevitable. Full pre release testing for a mineral SPF batch, the assay for zinc content, the microbial count, the stability panel, the trace metals panel, usually runs $800 to $1,500 per lot when a brand pays a third party contract lab. A 500 tube run of $28 sunscreen grosses about $14,000 at retail, which the brand splits with retailers. A single lot's testing bill eats double digit percent of margin. That is the arithmetic that produces skipped tests, and it is why the Kabana story is a category story, not a one company story.

What our shelf scan data shows

We audited the labels of 47 mineral sunscreens marketed as "clean," "organic," or "non toxic" pulled from Skinventry app scans over the past year, then cross referenced the brands against the FDA warning letter database. Six of the 47 brands, roughly 13%, had a live or recently closed warning letter or an untitled letter on file, most for cGMP or labeling issues. None had a formal recall as recent as Kabana's. What this tells us: the pattern isn't one bad actor. It's a systemic quality gap in the micro brand end of the mineral SPF market, and any consumer buying a small batch mineral tube should assume internal testing is lighter than what a big house like Neutrogena or La Roche Posay does. That's a fair assumption, not a slur. It's the price of small batch.

What to do if you own a recalled Kabana tube

Check the front of the tube against the four product names above. If it matches, and the lot number is one of the recalled ones (410 001, 404 003, or 404 001 for B Natural Organics; 405 002 or 405 003 for Green Screen; 408 002 for In Your Face; 410 002 for Erin's Faces), stop using it. The FDA guidance is to dispose of the product and contact your point of purchase for a refund.

Replacing it is easy. If you want to understand why mineral SPFs behave the way they do on skin, we broke that mechanism down in our explainer on how mineral filters actually work, and if you want to understand what the SPF number is really telling you, this piece on real world SPF delivery is where I would start. On the label reading side, our piece on why dermatologists trust synthetic formulas gets at why 'natural' isn't a QC standard.

Three things I read while writing this

• The full Kabana warning letter (FDA, July 18, 2025). Nine pages. The section on quality unit failures is the one to read.
• The earlier Kabana warning letter (FDA, March 12, 2025), which covers the recall trigger.
• WHO's January 2023 alert on contaminated cough syrups. Same category of failure. Same test that would have caught it.